Matriptase, a mouse type II membrane serine protease encoded by the ST14 (suppression of tumorigenicity 14) gene, is also known as epithin, and membrane-type serine protease 1/MT-SP1 (1-2). Its human ortholog MT-SP1/Matriptase (Catalog # http://www.rndsystems.com/product_results.aspx?k=3946-SE">3946-SE), which shares 81% amino acid identity with epithin, has been thought to play an important role in tumor biology and is a potential target for anti-cancer therapy (3). Matriptase has a multidomain structure containing a putative N-terminal transmembrane region, two CUB domains, four LDLRA repeats, and a C-terminal serine protease domain (1). The protease domain of epithin starts with Val615. R&D Systems recombinant mouse Matriptase is an active protease and consists of the catalytic domain (Val615 to Val855) and a short peptide (Gly596 to Arg614).
Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF
R&D Systems | Catalog # 4735-SE
Loading...
Key Product Details
- R&D Systems E. coli-derived Recombinant Mouse Matriptase/ST14 Catalytic Domain (4735-SE)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
E. coli
Accession Number
Applications
Enzyme Activity
Loading...
Product Specifications
Source
E. coli-derived mouse Matriptase/ST14 protein
Gly596-Val855, with an N-terminal Met and 6-His tag
The protein was auto-activated and further purified.
Gly596-Val855, with an N-terminal Met and 6-His tag
The protein was auto-activated and further purified.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met & Val615
Predicted Molecular Mass
3 kDa & 26 kDa
SDS-PAGE
27 kDa (major) and minor auto-activation fragments, reducing conditions
Activity
Measured by its ability to cleave the fluorogenic peptide substrate Boc-QAR-AMC (Catalog # ES014).
The specific activity is >4,000 pmol/min/µg, as measured under the described conditions.
The specific activity is >4,000 pmol/min/µg, as measured under the described conditions.
Reviewed Applications
Read 1 review rated 5 using 4735-SE in the following applications:
Formulation, Preparation, and Storage
4735-SE
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and Glycerol. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Matriptase/ST14
References
- Cho, E. et al. (2001) J. Biol. Chem. 276:44581.
- List, K. et al. (2006) Mol. Med. 12:1.
- Uhland, K. (2006) Cell Mol. Life Sci. 63:2968.
Alternate Names
Epithin, MTSP1, PRSS14, SNC19, ST14, TADG-15, TMPRSS14
Gene Symbol
ST14
UniProt
Additional Matriptase/ST14 Products
Product Documents for Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF
For research use only
Related Research Areas
Citations for Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF
Customer Reviews for Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF (1)
5 out of 5
1 Customer Rating
Have you used Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Showing
1
-
1 of
1 review
Showing All
Filter By:
-
Application: In vitro bioactivity in cell cultureVerified Customer | Posted 11/03/2016
There are no reviews that match your criteria.
Protocols
View specific protocols for Recombinant Mouse Matriptase/ST14 Catalytic Domain, CF (4735-SE):
Materials
- Assay Buffer: 50 mM Tris, 50 mM NaCl, 0.01% (v/v) Tween® 20, pH 9.0
- Recombinant Mouse Matriptase/ST14 Catalytic Domain (rmMatriptase) (Catalog # 4735-SE)
- Substrate: BOC-Gln-Ala-Arg-AMC (Catalog # ES014)
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rmMatriptase to 0.2 ng/µL in Assay Buffer.
- Dilute Substrate to 50 µM in Assay Buffer.
- Load into a plate 50 µL of 0.2 ng/µL rmMatriptase, and start the reaction by adding 50 µL of 50 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 50 µM Substrate.
- Read at excitation and emission wavelengths of 380 nm and 460 nm, respectively, in kinetic mode for 5 minutes.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 7-Amino, 4-Methyl Coumarin (Sigma, Catalog # A9891).
Per Well:
- rmMatriptase: 0.010 µg
- Substrate: 25 µM
Loading...